Markets:

Overview

News

Currencies

International

Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

1.070 +0.060 (+5.94%)

Streaming Delayed Price Updated: 10:26 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anebulo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 03, 2022

Gainers

Via Benzinga

Lower Doses Of Anebulo's ANEB-001 Reduces Negative Effects Of Higher Doses Of THC ↗

September 26, 2022

Via Benzinga

Anebulo's ANEB-001 Reduces Cannabis Intoxication In Healthy Participants ↗

July 05, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 18, 2022

During Tuesday's session, 78 companies made new 52-week lows.

Via Benzinga

Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing

September 26, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗

October 03, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Via Benzinga

Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

September 26, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022

September 20, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharma Posts FY 2022 Earnings, Positive Results From Clinical Trial For Treatment Of Acute Cannabinoid Intoxication ↗

September 09, 2022

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse,...

Via Benzinga

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress

September 09, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26

August 23, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022 ↗

July 27, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 14, 2022

Via Benzinga

Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session ↗

July 14, 2022

Gainers Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume.

Via Benzinga

Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗

July 15, 2022

Gainers

Via Benzinga

Why U.S. Stocks Are Trading Lower; Tesla Shares Drop After Price Target Cut At JPMorgan ↗

July 05, 2022

U.S. stocks traded sharply lower this morning, after the major indices closed another losing week. The Dow Jones gained around 200 points on Friday.

Via Benzinga

Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session ↗

July 05, 2022

Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.

Via Benzinga

Suffering From Acute Cannabinoid Intoxication? Anebulo Is Getting Closer To Investigational New Drug Application ↗

July 05, 2022

Anebulo Pharmaceuticals, Inc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 05, 2022

Via Benzinga

Anebulo Shares Gain After Positive Topline Results From Mid-stage Study Of Cannabinoid Intoxication Candidate ↗

July 05, 2022

Anebulo Pharmaceuticals (NASDAQ: ANEB) announced positive topline data from Part A of an ongoing Phase 2 clinical trial of its drug candidate ANEB-001 for patients with acute cannabinoid intoxication...

Via Benzinga

Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

July 05, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 28, 2022

Gainers

Via Benzinga

Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session ↗

June 24, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.

Via Benzinga

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

June 23, 2022

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗

June 24, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More ↗

June 23, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.